Skip to main content
Caplight Logo









ThinkBio.Ai, Inc.

ThinkBio.Ai, Inc.

Private
Ontario, CaliforniaHealthcare & Life Scienceshttps://www.thinkbio.ai/

Last Round

Early Stage

VC

May 18, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ThinkBio.Ai, Inc. is a biotechnology company that provides an AI-powered digital biology platform to accelerate discovery and improve clinical outcomes for biopharma and healthcare organizations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

computational biologydrug discovery platformmulti-omics platformAI research copilotbiopharma AIprecision medicinebiological knowledge graphdrug repurposingreal-world evidenceRWEclinical trial optimizationspatial biologypathology image analysisfederated data platformresponder identificationInsight-As-A-ServiceIAAS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ThinkBio.Ai, Inc. Comparables

Compare ThinkBio.Ai, Inc. with similar companies based on industry and business-model similarity.

ThinkBio.Ai, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ephemeral Technologies, Inc.
76%
Insilico Medicine
73%
Velsera
73%

ThinkBio.Ai, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMay 18, 2026

Key People

Founding team and executive leadership

Kevin Fleming

Board Member & Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 104% MoM, reaching 7.5K.

  • May 18, 2026

    Raised an early stage venture capital round.

ThinkBio.Ai, Inc. Filings

Explore SEC and related filing metadata, where available.

ThinkBio.Ai, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ThinkBio.Ai, Inc.'s valuation, stock price, and market status.

Is ThinkBio.Ai, Inc. a public or private company?

ThinkBio.Ai, Inc. is a private company.

What is the current stock price of ThinkBio.Ai, Inc.?

ThinkBio.Ai, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is ThinkBio.Ai, Inc. worth (valuation)?

Valuation information for ThinkBio.Ai, Inc. is not publicly available.

Can I buy ThinkBio.Ai, Inc. stock?

ThinkBio.Ai, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ThinkBio.Ai, Inc.'s last funding round?

ThinkBio.Ai, Inc.'s most recent funding round was Early Stage VC on May 18, 2026.

Who are the main investors in ThinkBio.Ai, Inc.?

Investor information for ThinkBio.Ai, Inc. is not publicly disclosed.

Will ThinkBio.Ai, Inc. IPO soon?

No public IPO plans have been announced for ThinkBio.Ai, Inc..

How can I track ThinkBio.Ai, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ThinkBio.Ai, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOntario, California
Employee Range63
Year Founded2024
Last FundingMay 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?